Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-22-026888

General Counsel sold 660 shares at $11.75 ($7,755)

  • General Counsel acquired 1,924 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ring Christine · General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-04-30 Exercise or conversion : show line 1 in the form +1,924 4,063 D
2022-05-02 Sale : show line 2 in the form −660 $11.75 $7,755 3,403 D
Open-market sales · 660 sh · avg $11.75 · $7,755

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-04-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,924 28,861 D
Loading xslF345X03/doc4.xml…